Childbirth-related Post-traumatic Stress Disorder in Switzerland: The Swiss Cohort on Traumatic Childbirth and Health (SwiTCH)

May 9, 2023 updated by: Antje Horsch, Centre Hospitalier Universitaire Vaudois

Childbirth-related Post-traumatic Stress Disorder in Switzerland and Understanding Its Relations With Depression, Health Care Renunciation, Coparenting and Parental Burnout: The Swiss Cohort on Traumatic Childbirth and Health

The goal of this observational study is to investigate the prevalence of Childbirth post-traumatic stress disorder (CB-PTSD) and Childbirth post-traumatic stress symptom (CB-PTSS) in Switzerland, and to analyze the psychological, medical, and social factors linked with CB-PTSD and CB-PTSS, whether they are antecedent factors or further consequences.

The main questions it aims to answer are :

  • The prevalence of CB-PTSS and CB-PTSD in Switzerland, for both mothers and partners (Primary outcome)
  • The risk and protective factors of CB-PTSD and CB-PTSS (Secondary outcome)
  • The impact of CB-PTSD and CB-PTSS on the marital and co-parental adjustment and the bonding with the infant (Secondary outcome)
  • The role of the childbirth experience on the triggering of CB-PTSD and CB-PTSS, including emotional and affective aspects (Secondary outcome)
  • The social and economic determinants of CB-PTSD and CB-PTSS, including, for example, social support and religion (Secondary outcome)

Participants will fill up surveys at four time points:

  • T1, during the third trimester of pregnancy
  • T2, at 6 to 12 weeks post-partum
  • T3, at 6 months post-partum
  • T4, at 12 months post-partum

Study Overview

Status

Recruiting

Detailed Description

Study design:

The present study consists of a longitudinal cohort study with surveys at four time points:

  • T1: Third trimester of pregnancy: including risk and protective factors for PTSD such as antenatal stress, mother-partner relationships, social support, current anxiety and depression, and history of mental health issues and treatments. Sociodemographic information is also collected at this time.
  • T2: 6-12 weeks postpartum: focusing on delivery conditions and its consequences with an extra focus on determining whether childbirth included eligible traumatic events such as e.g. emergency C-section, forceps, vacuum. The survey also investigates immediate PTSD onsets and other short-term outcomes such as early co-parenting quality and parent-infant bonding.
  • T3: 6 months postpartum: including reassessment of CB-PTSD since CB-PTSD occurring more than 6 months after the traumatic event represents the "delayed PTSD" subtype.
  • T4: 12 months postpartum: in order to identify the prevalence of delayed CB-PTSD, or of persistent/recurrent perinatal depression, to assess parent healthcare renunciation, as well as couple relationship quality/satisfaction and co-parenting quality.

Participants enter the SwiTCH study preferably at T1, but inclusion at T2 is also possible in order to maximize recruitment. The participants included at t2 will fill the sociodemographic and history of mental health surveys at T2 instead of T1.

Study population:

The inclusion criteria for mothers is being pregnant in the third pregnancy trimester and being above 16 years, or being between 6 to 12 weeks postpartum and above 16 years. Partners are recruited based on the inclusion criteria for mothers. Additionally, they must be 16 years old or older.

All participants are asked to sign a written consent (and if applicable, legal representatives for adolescents aged over 16 years old).

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Vaud
      • Lausanne, Vaud, Switzerland, 1011
        • Recruiting
        • Lausanne University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The population speaks French since the surveys are in French. The population is recruited in the French speaking part of Switzerland (Vaud, Neuchâtel, Geneva, Friburg, Wallis) in Lausanne University Hospital, in regional hospitals, and at independant healthcare professionals (such as midwifes, gynecologist, doulas...)

Description

Inclusion Criteria:

  • Women being pregnant in the third pregnancy trimester, or being between 6 to 12 weeks postpartum. Partners are recruited base on the inclusion criteria for mothers.

Exclusion Criteria:

  • N/A.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of childbirth trauma in mother and partner
Time Frame: 6-12 weeks postpartum
Measure of the extent to which the birth is perceived as traumatic
6-12 weeks postpartum
Prevalence of childbirth Posttraumatic Stress Disorder (PTSD) and childbirth Postraumatic Stress Symptoms (PTSS)
Time Frame: 6-12 weeks postpartum
Childbirth-related PTSD and PTSS is assessed with the City Birth Trauma Scale (City BiTS).
6-12 weeks postpartum
Prevalence of childbirth Posttraumatic Stress Disorder (PTSD) and childbirth Postraumatic Stress Symptoms (PTSS)
Time Frame: 6 months postpartum
Childbirth-related PTSD and PTSS is assessed with the City Birth Trauma Scale (City BiTS).
6 months postpartum
Prevalence of childbirth Posttraumatic Stress Disorder (PTSD) and childbirth Postraumatic Stress Symptoms (PTSS)
Time Frame: 12 months postpartum
Childbirth-related PTSD and PTSS is assessed with the City Birth Trauma Scale (City BiTS).
12 months postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors of CB-PTSD : History of mental health issues (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
History of mental health issues/treatment, 4 items
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : History of mental health issues (Partner)
Time Frame: Baseline (Third trimester of pregnancy)
History of mental health issues/treatment, 4 items
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Anxiety (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Anxiety (Partner)
Time Frame: Baseline (Third trimester of pregnancy)
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Depression (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Depression (Patner)
Time Frame: Baseline (Third trimester of pregnancy)
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Fear of childbirth I (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Fear of childbirth, 1 item
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Fear of childbirth (Partner)
Time Frame: Baseline (Third trimester of pregnancy)
Fear of childbirth, 1 item
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Fear of childbirth II (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Fear of Childbirth Questionnaire (FCQ; Slade et al., 2022), 20 items scored on a 4-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Antenatal Stress (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Antenatal Perceived Stress Inventory (APSI (Razurel et al., 2014), 12 items scored on a 5-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Previous trauma (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Previous birth trauma, 1 item
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Previous trauma (Partner)
Time Frame: Baseline (Third trimester of pregnancy)
Previous birth trauma, 1 item
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Previous birth trauma (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Previous birth trauma, 1 item
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Previous birth trauma (Partner)
Time Frame: Baseline (Third trimester of pregnancy)
Previous birth trauma, 1 item
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Prenatal attachment (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Prenatal Attachment Inventory (PAI; Jurgens et al., 2010), 21 items scored on a 4-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Relationship satisfaction (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Relationship assessment scale (RAS; Saramago et al., 2021), 7 items scored on a 5-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Relationship satisfaction (Partner)
Time Frame: Baseline (Third trimester of pregnancy)
Relationship assessment scale (RAS; Saramago et al., 2021), 7 items scored on a 5-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Social Support (Mother)
Time Frame: Baseline (Third trimester of pregnancy)
Modified Medical Outcomes Study Social Support Survey (mMOS-SS; Moser et al., 2012), 8 items scored on a 5-point scale
Baseline (Third trimester of pregnancy)
Risk factors of CB-PTSD : Social Support (Partner)
Time Frame: Baseline (Third trimester of pregnancy)
Modified Medical Outcomes Study Social Support Survey (mMOS-SS; Moser et al., 2012), 8 items scored on a 5-point scale
Baseline (Third trimester of pregnancy)
Consequences of CB-PTSD : Anxiety (Mother)
Time Frame: 6-12 weeks postpartum
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Anxiety (Partner)
Time Frame: 6-12 weeks postpartum
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Depression (Mother)
Time Frame: 6-12 weeks postpartum
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Depression (Partner)
Time Frame: 6-12 weeks postpartum
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Mother-infant bonding I (Mother)
Time Frame: 6-12 weeks postpartum
Postpartum Bonding Questionnaire (PPBQ; Demanche et al., 2021), 25 items scored on a 5-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Mother-infant bonding II (Mother)
Time Frame: 6-12 weeks postpartum
Parent-Infant Bonding Scale (MIBS; Bienfait et al., 2017), 8 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Father-infant bonding (Partner)
Time Frame: 6-12 weeks postpartum
Parent-Infant Bonding Scale (MIBS; Bienfait et al., 2017), 8 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Relationship satisfaction (Mother)
Time Frame: 6-12 weeks postpartum
Relationship assessment scale (RAS; Saramago et al., 2021), 7 items scored on a 5-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Relationship satisfaction (Partner)
Time Frame: 6-12 weeks postpartum
Relationship assessment scale (RAS; Saramago et al., 2021), 7 items scored on a 5-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Coparenting (Mother)
Time Frame: 6-12 weeks postpartum
Coparenting Relationship Scale (CRS; Favez et al., 2021), 35 items scored on a 7-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Coparenting (Partner)
Time Frame: 6-12 weeks postpartum
Coparenting Relationship Scale (CRS; Favez et al., 2021), 35 items scored on a 7-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Parenting self-efficacy (Mother)
Time Frame: 6-12 weeks postpartum
Perceived Maternal Parenting Self-Efficacy (PMP-SE; Schneider et al., 2019), 20 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Parenting self-efficacy (Partner)
Time Frame: 6-12 weeks postpartum
Perceived Maternal Parenting Self-Efficacy (PMP-SE; Schneider et al., 2019), 20 items scored on a 4-point scale
6-12 weeks postpartum
Consequences of CB-PTSD : Healthcare renunciation (Mother)
Time Frame: 6-12 weeks postpartum
Healthcare renunciation, 3 items
6-12 weeks postpartum
Consequences of CB-PTSD : Healthcare renunciation (Partner)
Time Frame: 6-12 weeks postpartum
Healthcare renunciation, 3 items
6-12 weeks postpartum
Consequences of CB-PTSD : Anxiety (Mother)
Time Frame: 6 months postpartum
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
6 months postpartum
Consequences of CB-PTSD : Anxiety (Partner)
Time Frame: 6 months postpartum
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
6 months postpartum
Consequences of CB-PTSD : Depression (Mother)
Time Frame: 6 months postpartum
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
6 months postpartum
Consequences of CB-PTSD : Depression (Partner)
Time Frame: 6 months postpartum
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
6 months postpartum
Consequences of CB-PTSD : Mother-infant bonding (Mother)
Time Frame: 6 months postpartum
Postpartum Bonding Questionnaire (PPBQ; Demanche et al., 2021), 25 items scored on a 5-point scale
6 months postpartum
Consequences of CB-PTSD : Support from neighborhood (Mother)
Time Frame: 6 months postpartum
Perceived Neighborhood Social Cohesion (P-NSC; Dupuis et al., 2017), 9 items scored on a 7-point scale
6 months postpartum
Consequences of CB-PTSD : Support from neighborhood (Partner)
Time Frame: 6 months postpartum
Perceived Neighborhood Social Cohesion (P-NSC; Dupuis et al., 2017), 9 items scored on a 7-point scale
6 months postpartum
Consequences of CB-PTSD : Anxiety (Mother)
Time Frame: 12 months postpartum
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
12 months postpartum
Consequences of CB-PTSD : Anxiety (Partner)
Time Frame: 12 months postpartum
Hospital Anxiety and Depression Scale (HADS; Untas et al., 2009), 7 items scored on a 4-point scale
12 months postpartum
Consequences of CB-PTSD : Depression (Mother)
Time Frame: 12 months postpartum
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
12 months postpartum
Consequences of CB-PTSD : Depression (Partner)
Time Frame: 12 months postpartum
Edinburgh Postnatal Depression Scale (EPDS; Guedeney et al., 1998), 10 items scored on a 4-point scale
12 months postpartum
Consequences of CB-PTSD : Relationship satisfaction (Mother)
Time Frame: 12 months postpartum
Relationship assessment scale (RAS; Saramago et al., 2021), 7 items scored on a 5-point scale
12 months postpartum
Consequences of CB-PTSD : Relationship satisfaction (Partner)
Time Frame: 12 months postpartum
Relationship assessment scale (RAS; Saramago et al., 2021), 7 items scored on a 5-point scale
12 months postpartum
Consequences of CB-PTSD : Coparenting (Mother)
Time Frame: 12 months postpartum
Coparenting Relationship Scale (CRS; Favez et al., 2021), 35 items scored on a 7-point scale
12 months postpartum
Consequences of CB-PTSD : Coparenting (Partner)
Time Frame: 12 months postpartum
Coparenting Relationship Scale (CRS; Favez et al., 2021), 35 items scored on a 7-point scale
12 months postpartum
Consequences of CB-PTSD : Support from neighborhood (Mother)
Time Frame: 12 months postpartum
Perceived Neighborhood Social Cohesion (P-NSC; Dupuis et al., 2017), 9 items scored on a 7-point scale
12 months postpartum
Consequences of CB-PTSD : Support from neighborhood (Partner)
Time Frame: 12 months postpartum
Perceived Neighborhood Social Cohesion (P-NSC; Dupuis et al., 2017), 9 items scored on a 7-point scale
12 months postpartum
Consequences of CB-PTSD : Healthcare renunciation (Mother)
Time Frame: 12 months postpartum
Healthcare renunciation, 3 items
12 months postpartum
Consequences of CB-PTSD : Healthcare renunciation (Partner)
Time Frame: 12 months postpartum
Healthcare renunciation, 3 items
12 months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antje Horsch, UNIL-CHUV

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Anticipated)

December 1, 2024

Study Completion (Anticipated)

December 1, 2025

Study Registration Dates

First Submitted

March 21, 2023

First Submitted That Met QC Criteria

May 9, 2023

First Posted (Actual)

May 19, 2023

Study Record Updates

Last Update Posted (Actual)

May 19, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The IPD will be available upon request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder

Subscribe